<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05060393</url>
  </required_header>
  <id_info>
    <org_study_id>202100452</org_study_id>
    <nct_id>NCT05060393</nct_id>
  </id_info>
  <brief_title>Efficacy of Mindfulness-based Mobile Application Use in Patients With Depressive Disorder</brief_title>
  <official_title>Efficacy of Mindfulness-based Mobile Application Use in Patients With Depressive Disorder</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Basel</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Basel</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The presented randomized-controled study aim to assess the use of internet-based mindfulness&#xD;
      intervention via mobile application for 30 days in patients with Major Depressive Disorder&#xD;
      (MDD)&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Mindfulness-based interventions (MBI) proved to be effective in relapse prevention in MDD.&#xD;
      Next, MBI in form of free mobile applications can be an effective augmentation of the&#xD;
      treatment as usual (TAU) and can fill a gap in the ambulatory care. Given this background,&#xD;
      the aim of this randomized controlled study is to assess the effectiveness of additional MBI&#xD;
      via mobile app on the symptom severity and stress levels, compared to TAU.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 1, 2021</start_date>
  <completion_date type="Anticipated">January 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">October 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline self reported Depression Severity</measure>
    <time_frame>30 days</time_frame>
    <description>Beck Depression Inventory</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from Baseline Depression Severity</measure>
    <time_frame>30 days</time_frame>
    <description>Hamilton Depression Rating Scale</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from baseline heart rate</measure>
    <time_frame>30 days</time_frame>
    <description>Change in resting heart rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline blood pressure</measure>
    <time_frame>30 days</time_frame>
    <description>Change in systolic blood pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline respiratory rate</measure>
    <time_frame>30 days</time_frame>
    <description>Change in resting respiratory rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline tobacco consumption</measure>
    <time_frame>30 days</time_frame>
    <description>Change in daily tobacco consumption</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline alcohol consumption</measure>
    <time_frame>30 days</time_frame>
    <description>Change in weekly alcohol consumption</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in consumption of anxiolytics</measure>
    <time_frame>30 days</time_frame>
    <description>Change in daily use of anxiolytic drugs</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">140</enrollment>
  <condition>Depression</condition>
  <arm_group>
    <arm_group_label>Intervention group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Daily use of mindfulness-based mobile application for 30 days.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Treatment as usual</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Mindfulness-based cognitive therapy</intervention_name>
    <description>Mobile application, mindfulness-based therapy</description>
    <arm_group_label>Intervention group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Depression, current ill&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  acute alcohol- and drug dependency, schizophrenia or psychotic disorder, severe&#xD;
             somatic illnes, not having smartphone or not willing to use mobile application&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jan Sarlon</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Basel</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jan Sarlon</last_name>
    <phone>+41613255381</phone>
    <email>jan.sarlon@upk.ch</email>
  </overall_contact>
  <location>
    <facility>
      <name>Jan Sarlon</name>
      <address>
        <city>Basel</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jan Sarlon</last_name>
      <phone>+41613255381</phone>
      <email>jan.sarlon@upk.ch</email>
    </contact>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 8, 2021</study_first_submitted>
  <study_first_submitted_qc>September 17, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 29, 2021</study_first_posted>
  <last_update_submitted>September 17, 2021</last_update_submitted>
  <last_update_submitted_qc>September 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Basel</investigator_affiliation>
    <investigator_full_name>Jan Sarlon</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depressive Disorder</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>All of the individual participant data collected during the trial will be shared, after deidentification.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_time_frame>Immediately following publication and ending 5 years following article publication.</ipd_time_frame>
    <ipd_access_criteria>Researchers who provide a methodologically sound proposal.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

